Clinical Outcomes a Median of 2.5 Years After Initial Ablation Using Suppressed Thyroglobulin of Less Than 1 ng/mL and Stimulated Thyroglobulin of Less Than 2 ng/mL to Define NCED
| Parameter | NCED | Clinical recurrence | Persistent disease | TB uptake Only | P |
|---|---|---|---|---|---|
| THW (n = 74) | 55.4% (41) | 6.8% (5) | 32.4% (24) | 5.4% (4) | 0.021 |
| rhTSH (n = 320) | 73.8% (236) | 3.8% (12) | 19.4% (62) | 3.1% (10) | |
| Total (n = 394) | 70.3% (277) | 4.3% (17) | 21.8% (86) | 3.6% (14) |
TB = thyroid bed.